We now have the blessing of gene and cell therapies, which are great in terms of their effectiveness, but they are super, super expensive
Ongoing support A prescribers job is not to just make the medications available to you, but be there when you need them the most, especially during transition when the chances of side effects are high
The supplement industry rushed to capitalize on GLP-1 popularity, flooding the market with products making bold claims
The studys limitations include a predominantly White population from the United States (US), a trial duration of one year, rescue therapy after week 24 that limited pure placebo comparisons, and the lack of continued treatment with injectables as a comparator
5 Ye, Z
The FDA allows personalized GLP-1s that have modified formulations or customized doses to be prescribed at the clinicians discretion